Clinical Trials Logo

Aortic Arch clinical trials

View clinical trials related to Aortic Arch.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05530304 Recruiting - Clinical trials for Aortic Arch Aneurysm

Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.

triple_branch
Start date: February 9, 2023
Phase:
Study type: Observational [Patient Registry]

Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.

NCT ID: NCT04995640 Recruiting - Aortic Diseases Clinical Trials

CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair

Start date: October 1, 2021
Phase:
Study type: Observational

This registry aims to provide insights on the pathogenic mechanisms that expose subjects with CILCA arch to the increased risk of postoperative complications. So, the CILCA arch registry will capture clinical data and medical images of subjects with CILCA arch treated by surgical or endovascular (TEVAR) means. Study Design: International Multicenter and Observational registry Estimated Enrolment: 500 patients, with competitive enrolment. Clinical Follow up: Postoperatively at 30 days, at 12 months, and yearly after.

NCT ID: NCT04966247 Recruiting - Aortic Aneurysm Clinical Trials

Cerebral Protection in Aortic Arch Surgery

Start date: August 1, 2023
Phase:
Study type: Observational

Aortic arch repair surgery is a technically complex and challenging procedure to treat aortic pathologies. Despite advancements in perioperative care, detrimental neurological complications occur during or after surgery. The neurological complications increase the economic burden of healthcare, morbidity and quality of life for the patients, even if they survive. Stroke, for example, leads to an increase in healthcare and social care costs, requiring a subsequent lengthy rehabilitation. Milder neurological impairments include transient ischaemic attacks, confusion and delirium, necessitating longer intensive care and hospital stay. Currently applied cerebral monitoring modalities are electroencephalogram and cerebral oximetry. However, they are not specific enough to timely detect early cerebral ischaemia to prevent neurological complications. S100B protein and neuron-specific enolase are serum markers that reflect cerebral damage, however, their applicability in the hyperacute setting is limited. However, rapid measurements of glial fibrillary protein have paved new pathways to detect cerebral injury. Recent studies reveal more sensitive biomarkers of glucose, lactate, pyruvate, glutamate and glycerol. These biomarkers could potentially detect cerebral ischaemia on a near real-time basis using the microdialysis method. The aim of the project is to develop a bedside system for early detection of cerebral ischaemia on a near real-time basis during aortic arch surgery. Early detection of cerebral ischaemia could mandate more aggressive cerebral protection strategies by further optimisation of hypothermia and antegrade selective cerebral perfusion during surgery, and optimisation of blood pressure and oxygenation in the intensive care unit. Ultimately, early detection of cerebral ischemia during surgery will prevent disabling and costly neurological complications following surgery.

NCT ID: NCT04545502 Recruiting - Aneurysm Clinical Trials

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

PANTHER
Start date: February 17, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice. Data will be collected both retrospectively and prospectively.